AXSM — AXSOME THERAPEUTICS INC

Ownership history in SUPERSTRING CAPITAL MANAGEMENT LP  ·  4 quarters on record

This page tracks every 13F SEC filing in which SUPERSTRING CAPITAL MANAGEMENT LP reported a position in AXSOME THERAPEUTICS INC (AXSM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.66% (2025 Q4)
Avg. % of fund
1.71%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 37,433 +33,165 +777.1% 3.66% $6.8M $182.64
2024 Q4 REDUCED 4,268 -32,339 -88.3% 0.31% $361K $84.61
2024 Q1 ADDED 36,607 +20,428 +126.3% 1.93% $2.9M $79.80
2023 Q4 INITIATED 16,179 — — 0.92% $1.3M —
% of Fund (quarterly)    AXSM price (monthly, adj. close)

Other funds also holding AXSM

As of 2025 Q4 — sorted by position size

ALETHEA CAPITAL MANAGEMENT, LLC 3Y 7Y 59.3% IRIDIAN ASSET MANAGEMENT LLC/CT 3Y 7Y 4.96% Tri Locum Partners LP 3Y 4.78% PFM Health Sciences, LP 3Y 7Y 4.58% Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 4.52% First Turn Management, LLC 4.32% Deep Track Capital, LP 3Y 3.74% Rhenman & Partners Asset Management AB 3Y 7Y 1.96% Privium Fund Management B.V. 3Y 1.91% Seven Fleet Capital Management LP 1.8%
← Back to SUPERSTRING CAPITAL MANAGEMENT LP Holdings